{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:02:12Z","timestamp":1794474132130,"version":"4.9.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clinbiochem.2024.110812","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T02:28:08Z","timestamp":1724725688000},"page":"110812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Lipidomic profiling in patients with familial hypercholesterolemia: Abnormalities in glycerolipids and oxysterols"],"prefix":"10.1016","volume":"131-132","author":[{"given":"Shiva","family":"Ganjali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimiro","family":"Cardenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"Bonciolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Al-Rasadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110812_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110812_b0010","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJMoa1913805","article-title":"Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia","volume":"382","author":"Raal","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.clinbiochem.2024.110812_b0015","doi-asserted-by":"crossref","first-page":"e013225","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"13","key":"10.1016\/j.clinbiochem.2024.110812_b0020","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/eurheartj\/eht015","article-title":"Diagnosis and treatment of familial hypercholesterolaemia","volume":"34","author":"Hovingh","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0025","article-title":"Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management","author":"Mytilinaiou","year":"20189707","journal-title":"Front Pharmacol."},{"issue":"32","key":"10.1016\/j.clinbiochem.2024.110812_b0030","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110812_b0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11883-014-0482-5","article-title":"Familial Hypercholesterolemia\u2014Epidemiology, Diagnosis, and Screening","volume":"17","author":"Singh","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"issue":"25","key":"10.1016\/j.clinbiochem.2024.110812_b0040","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110812_b0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/clc.22223","article-title":"Familial Hypercholesterolemia: An Under-recognized but Significant Concern in Cardiology Practice","volume":"37","author":"Foody","year":"2014","journal-title":"Clin. Cardiol."},{"issue":"10421","key":"10.1016\/j.clinbiochem.2024.110812_b0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(23)01842-1","article-title":"Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study","volume":"403","author":"Dharmayat","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110812_b0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2015.09.021","article-title":"Familial hypercholesterolaemia: A global call to arms","volume":"243","author":"Vallejo-Vaz","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2024.110812_b0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.atherosclerosis.2018.08.051","article-title":"Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"277","author":"Vallejo-Vaz","year":"2018","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110812_b0065","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.clinthera.2013.06.019","article-title":"New LDL-cholesterol lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes","volume":"35","author":"Sahebkar","year":"2013","journal-title":"Clin. Ther."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110812_b0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10557-013-6479-4","article-title":"New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: What can the clinician expect?","volume":"27","author":"Sahebkar","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110812_b0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40256-023-00594-5","article-title":"Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention","volume":"23","author":"Michaeli","year":"2023","journal-title":"Am J Cardiovasc Drugs."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110812_b0080","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4093\/dmj.2022.0295","article-title":"New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins","volume":"46","author":"Kim","year":"2022","journal-title":"Diabetes Metab J."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110812_b0085","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110812_b0090","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.111.227181","article-title":"Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia","volume":"31","author":"Bellanger","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110812_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2012.06.010","article-title":"Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS\/MS","volume":"224","author":"St\u00fcbiger","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110812_b0100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.clnu.2021.11.033","article-title":"Serum lysophospholipidome of dietary origin as a suitable susceptibility\/risk biomarker of human hypercholesterolemia: A cross-sectional study","volume":"41","author":"Calder\u00f3n-P\u00e9rez","year":"2022","journal-title":"Clin. Nutr."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110812_b0105","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1242\/bio.019802","article-title":"A lipidomics study reveals hepatic lipid signatures associating with deficiency of the LDL receptor in a rat model","volume":"5","author":"Wang","year":"2016","journal-title":"Biology Open."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110812_b0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/omi.2016.0178","article-title":"Novel lipidomic biomarkers in hyperlipidemia and cardiovascular diseases: an integrative biology analysis","volume":"21","author":"Rai","year":"2017","journal-title":"OMICS"},{"key":"10.1016\/j.clinbiochem.2024.110812_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100127","article-title":"Clinical Lipidomics: Realizing the potential of lipid profiling","volume":"62","author":"Meikle","year":"2021","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2016.180","article-title":"Lipidomics refines CVD risk prediction","author":"Ummarino","year":"20161312697","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110812_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11883-010-0110-y","article-title":"Lipidomics: a tool for studies of atherosclerosis","volume":"12","author":"Ekroos","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110812_b0130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bbrc.2018.04.106","article-title":"Lipidomic insight into cardiovascular diseases","volume":"504","author":"Kohno","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110812_b0135","first-page":"941","article-title":"Lipidomics: quest for molecular lipid biomarkers in cardiovascular disease. Circulation: Cardiovascular","volume":"7","author":"Hinterwirth","year":"2014","journal-title":"Genetics"},{"key":"10.1016\/j.clinbiochem.2024.110812_b0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.24075\/brsmu.2019.090","article-title":"Lipidome features in patients with different probability of family hypercholesterolemia","volume":"6","author":"Rogozhina","year":"2019","journal-title":"Bulletin of Russian State Medical University."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105430","article-title":"Nutraceuticals and physical activity: Their role on oxysterols-mediated neurodegeneration","volume":"193","author":"Malaguti","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.redox.2018.02.014","article-title":"Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia","volume":"16","author":"Dias","year":"2018","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110812_b0155","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0019","article-title":"Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia","volume":"11","author":"Chan","year":"2022","journal-title":"Endocr. Connect."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110812_b0160","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12161-010-9190-0","article-title":"Comparison of the determination of eight cholesterol oxides in dry\u2013cured shoulder by GC\u2013FID, GC\u2013MS, and GC tandem mass spectrometry","volume":"4","author":"Clariana","year":"2011","journal-title":"Food Anal. Methods"},{"issue":"49","key":"10.1016\/j.clinbiochem.2024.110812_b0165","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1021\/acs.jafc.8b03097","article-title":"Evaluation of breed and parity order effects on the lipid composition of porcine colostrum","volume":"66","author":"Luise","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"44","key":"10.1016\/j.clinbiochem.2024.110812_b0170","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1021\/jf503200z","article-title":"Coffee silverskin: Characterization, possible uses, and safety aspects","volume":"62","author":"Toschi","year":"2014","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110812_b0175","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00216-011-5432-2","article-title":"Development and validation of a comprehensive two-dimensional gas chromatography\u2013mass spectrometry method for the analysis of phytosterol oxidation products in human plasma","volume":"402","author":"Men\u00e9ndez-Carre\u00f1o","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.meatsci.2015.02.010","article-title":"Effect of dietary supplementation on lipid photooxidation in beef meat, during storage under commercial retail conditions","volume":"105","author":"Cardenia","year":"2015","journal-title":"Meat Sci."},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110812_b0185","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1021\/ja00899a032","article-title":"Gas-liquid chromatography of trimethylsilyl derivatives of sugars and related substances","volume":"85","author":"Sweeley","year":"1963","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110812_b0190","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jssc.201100660","article-title":"Analysis of cholesterol oxidation products by fast gas chromatography\/mass spectrometry","volume":"35","author":"Cardenia","year":"2012","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0195","article-title":"Effect of rosuvastatin on the concentration of each fatty acid in the fraction of free fatty acids and total lipids in human plasma: The role of cholesterol homeostasis","volume":"24","author":"Ciucanu","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110812_b0200","doi-asserted-by":"crossref","first-page":"e5183","DOI":"10.1002\/bmc.5183","article-title":"Proteomics and metabolomics analyses reveal the full spectrum of inflammatory and lipid metabolic abnormalities in dyslipidemia","volume":"35","author":"Du","year":"2021","journal-title":"Biomed. Chromatogr."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110812_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121941","article-title":"An Untargeted Lipidomic Analysis Reveals Depletion of Several Phospholipid Classes in Patients with Familial Hypercholesterolemia on Treatment with Evolocumab","volume":"9","author":"Anesi","year":"2021","journal-title":"Biomedicines."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110812_b0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12944-018-0785-6","article-title":"Effects of aging on serum levels of lipid molecular species as determined by lipidomics analysis in Japanese men and women","volume":"17","author":"Kawanishi","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"13","key":"10.1016\/j.clinbiochem.2024.110812_b0215","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128438","article-title":"Changes in plasma lipids predict pravastatin efficacy in secondary prevention","volume":"4","author":"Jayawardana","year":"2019","journal-title":"JCI Insight."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110812_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11060340","article-title":"The Impact of Simvastatin on Lipidomic Markers of Cardiovascular Risk in Human Liver Cells Is Secondary to the Modulation of Intracellular Cholesterol","volume":"11","author":"Schooneveldt","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.clinbiochem.2024.110812_b0225","doi-asserted-by":"crossref","unstructured":"Klassen A, Sussulini A, Derogis P, Ferreira C, Lopes A, Cruz E, et al. Evaluation of Two Highly Effective Lipid-Lowering Therapies in Subjects With Acute Myocardial Infarction: A Lipidomic Analysis. 2021.","DOI":"10.21203\/rs.3.rs-154365\/v1"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110812_b0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/0929867327666200316142659","article-title":"A comprehensive review on oxysterols and related diseases","volume":"28","author":"Samadi","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113648","article-title":"7-Ketocholesterol and 7\u03b2-hydroxycholesterol: In vitro and animal models used to characterize their activities and to identify molecules preventing their toxicity","volume":"173","author":"Vejux","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0240","doi-asserted-by":"crossref","unstructured":"Salonen JT, Nyysso\u00a8 nen K, Salonen R, Porkkala-Sarataho E, Tuomainen T-P, Diczfalusy U, et al. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation. 1997;95(4):840-5.","DOI":"10.1161\/01.CIR.95.4.840"},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110812_b0245","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.ATV.19.4.967","article-title":"Increased plasma 7\u03b2-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease","volume":"19","author":"Zied\u00e9n","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101380","article-title":"7-Ketocholesterol in disease and aging","volume":"29","author":"Anderson","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.clinbiochem.2024.110812_b0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2020.11.013","article-title":"Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activation","volume":"315","author":"Reeskamp","year":"2020","journal-title":"Atherosclerosis"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024001061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024001061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T21:10:46Z","timestamp":1725916246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024001061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":51,"alternative-id":["S0009912024001061"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110812","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipidomic profiling in patients with familial hypercholesterolemia: Abnormalities in glycerolipids and oxysterols","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110812"}}